Insulin-loaded PLGA microspheres for glucose-responsive release.

about

Insulin-loaded PLGA microspheres for glucose-responsive release.

Item

http://www.wikidata.org/entity/Q47603482

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Insulin-loaded PLGA microspheres for glucose-responsive release.

@en

Insulin-loaded PLGA microspheres for glucose-responsive release.

@nl

type

Item

label

Insulin-loaded PLGA microspheres for glucose-responsive release.

@en

Insulin-loaded PLGA microspheres for glucose-responsive release.

@nl

prefLabel

Insulin-loaded PLGA microspheres for glucose-responsive release.

@en

Insulin-loaded PLGA microspheres for glucose-responsive release.

@nl

P1476

Insulin-loaded PLGA microspheres for glucose-responsive release.

@en

P2093

Dong-Xiu Wang

http://www.w3.org/2001/XMLSchema#string

Gareth R Williams

http://www.w3.org/2001/XMLSchema#string

He-Yu Li

http://www.w3.org/2001/XMLSchema#string

Jun-Zi Wu

http://www.w3.org/2001/XMLSchema#string

Li-Min Zhu

http://www.w3.org/2001/XMLSchema#string

Shu-De Li

http://www.w3.org/2001/XMLSchema#string

P2860

An overview of clinical and commercial impact of drug delivery systems

Standards of medical care in diabetes--2014

Injectable and Glucose-Responsive Hydrogels Based on Boronic Acid-Glucose Complexation

Technology-driven layer-by-layer assembly of nanofilms

Early developmental conditioning of later health and disease: physiology or pathophysiology?

Ultrasound-triggered regulation of blood glucose levels using injectable nano-network.

The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.

Glucose- and temperature-sensitive nanoparticles for insulin delivery

Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin

Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

P304

1513-1525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10717544.2017.1381200

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28975813

http://www.w3.org/2001/XMLSchema#string

P921

microspheres

glucose